Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01454206|
Recruitment Status : Withdrawn (The project was not funded)
First Posted : October 18, 2011
Last Update Posted : October 7, 2016
|Condition or disease||Intervention/treatment||Phase|
|Substance Use||Behavioral: iSBIRT||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||Integration of Internet-facilitated Screening, Brief Intervention, Referral to Treatment (iSBIRT) for Teen Drug Use Into a Pediatric Network|
|Study Start Date :||July 2012|
|Estimated Primary Completion Date :||October 2016|
|Estimated Study Completion Date :||December 2016|
|No Intervention: Treatment as Usual|
Participants will receive the internet-facilitated screening, brief intervention and referral to treatment (iSBIRT intervention)
Participants will be screened for substance use, view information about the health effects of substance use on the computer, and receive advice from the primary care provider regarding the health effects of substance use. Those found to be at "high risk" will complete an internet-based program encouraging them to change their substance use.
- Provider attitude toward iSBIRT [ Time Frame: 12 months post baseline ]We will evaluate providers' acceptance of and attitude toward integrating iSBIRT into their practices.
- Youth connectedness to provider [ Time Frame: Baseline ]We will measure adolescents' attitudes toward their providers' advice regarding the health effects of substance use given during the visit
- iSBIRT sustainability [ Time Frame: 12 months post ]We will measure rates of continued use of iSBIRT by practices 12 months after iSBIRT recruitment and implementation ends
- Change in rates of adolescent substance use [ Time Frame: 3 months post baseline ]We will measure the change in rates of adolescent substance use from baseline to 3 months post study visit.
- Change in rates of adolescent substance use [ Time Frame: 6 months post baseline ]We will measure the change in rates of adolescent substance use from baseline to 6 months post study visit.
- Change in rates of adolescent substance use [ Time Frame: 12 months post baseline ]We will measure the change in rates of adolescent substance use from baseline to 12 months post study visit.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01454206
|United States, Massachusetts|
|Children's Hospital Boston|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||John R Knight, MD||Boston Children’s Hospital|